Dataset from A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab and Taxane Based Therapy
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006479
下载链接
链接失效反馈官方服务：
资源简介：
This Phase II, double-blind, randomized, placebo-controlled multicenter study will
investigate the efficacy and safety of trastuzumab emtansine in combination with atezolizumab
or atezolizumab-placebo in participants with HER2-positive locally advanced or metastatic BC
who have received prior trastuzumab and taxane based therapy, either alone or in combination,
and/or who have progressed within 6 months after completing adjuvant therapy.
创建时间：
2026-03-27
